January 29, 2026
Ahead Therapeutics Awarded Breakthrough T1D IDDP Grant to Accelerate ASIT Platform Technology Development for Type 1 Diabetes
January 29, 2026
Breakthrough T1D Expresses Gratitude to Long-Time Partner Ford for Donating the Auction Proceeds of the First Mustang Dark Horse SC to Type 1 Diabetes Research
January 15, 2026
Breakthrough T1D Awards $1.5 Million Grant to Blue Circle Health to Expand Access to Care for Underserved Adults with Type 1 Diabetes
January 12, 2026
Breakthrough T1D Celebrates Tezeild Approval in the EU
January 12, 2026
Invictus Therapeutics and Breakthrough T1D Announce Collaboration to Support First-in-Human Trial of Next-Generation Insulin Analog
December 10, 2025
Breakthrough T1D-Led Paper Outlines First International Consensus Guidance for Continuous Ketone Monitoring in Diabetes
December 10, 2025
Syntax Bio Receives Award from Breakthrough T1D to Advance Pancreatic Beta Cell Therapy for Type 1 Diabetes
November 17, 2025
Pluristyx Collaborates with Breakthrough T1D to Make “Immune-Cloaked” and Safety Switch-Enabled Allogeneic Cell Line for Type 1 Diabetes Therapies
November 13, 2025
Breakthrough T1D Honors World Diabetes Day with “The State of T1D”
November 13, 2025
Breakthrough T1D, the Leading Global Type 1 Diabetes Research and Advocacy Organization, Expresses Gratitude for Extension of Special Diabetes Program
